Renvela 800 mg

RENVELA 800 MG tablets contain sevelamer carbonate, a phosphate binder used to manage high phosphate levels in the blood. This medication is commonly prescribed for patients undergoing dialysis.

RENVELA 800 MG tablets are primarily used to control phosphate levels in individuals with chronic kidney disease who are on dialysis. By binding to dietary phosphate in the gastrointestinal tract, sevelamer carbonate helps to reduce the absorption of phosphate, which can accumulate to harmful levels in the blood. This medication is often part of a broader treatment plan to manage kidney-related health issues.

Common effects of RENVELA 800 MG tablets may include gastrointestinal discomfort, such as nausea, vomiting, or diarrhea. Some users might also experience constipation or abdominal pain. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

RENVELA 800 MG tablets should be taken as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Additionally, individuals with a history of bowel obstruction or severe digestive issues should use this medication with caution.

RENVELA 800 MG tablets may interact with certain medications, including those that require careful monitoring of blood levels. It is advisable to consult a healthcare provider before taking this medication with other drugs, especially those metabolized by the liver or kidneys. Alcohol and other substances that affect digestion may also influence the effectiveness of sevelamer carbonate.